Work

Patient Perceptions of the Risks and Benefits of Infliximab for the Treatment of Inflammatory Bowel Disease

Year: 2006

Type: article

Study design: Observational Study

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-200609001-01120

Authors: Corey A. Siegel, Campbell Levy, Todd A. Mackenzie, Bruce E. Sands

Institutions: Dartmouth–Hitchcock Medical Center, Massachusetts General Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978426225

FWCI: 0.189

Cites:

Cited by: 1

Related to: 10